Lower risk Medical device recall · FDA · Published March 25, 2026

Remel Oxoid Agglutinating Sera Recall: Cross-reaction risk with Salmonella 9-0

Remel recalls Oxoid Agglutinating Sera (Salmonella 9-0 R30957301) due to cross-reaction with 2-0 serotypes. Affected lots may misidentify Salmonella 9-O as 2-O, risking incorrect identification in lab tests.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #Z-1923-2026Medical device Remel ›

Lower-risk recall

Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.

Take action

Contact the company

Recalling firmRemel Europe Ltd.Clipper Boulevard West, Ken · Dartford, United Kingdom

✎ GovInfoNow plain-language explainer

Remel is recalling specific lots of Oxoid Agglutinating Sera for Salmonella 9-0 testing. The product may cross-react with 2-0 serotypes, leading to misidentification of Salmonella 9-O as 2-O in lab tests. This could cause incorrect results in food safety testing. Read more at govinfonow.com/recall/49625-remel-oxoid-agglutinating-sera-recall-cross-reaction-risk-with-salmonella.

Source Summary by GovInfoNow · govinfonow.com/recall/49625-remel-oxoid-agglutinating-sera-recall-cross-reaction-risk-with-salmonella · Updated August 18, 2026 · FDA enforcement record: FDA #Z-1923-2026

Cite this page

“Remel Oxoid Agglutinating Sera Recall: Cross-reaction risk with Salmonella 9-0.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/49625-remel-oxoid-agglutinating-sera-recall-cross-reaction-risk-with-salmonella. Based on FDA recall #Z-1923-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1923-2026%22&limit=1).

The FDA announced on March 25, 2026, that Remel Europe Ltd. is recalling Oxoid Agglutinating Sera, Salmonella 9-0 due to cross-reactivity hazards. The agency issued recall number Z-1923-2026 for the device.

How to tell if you have it

Brand: Remel
Product: Oxoid Agglutinating Sera, Salmonella 9-0 R30957301
UDI-DI: 05056080500270
Lots: 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858
Distribution: US Nationwide in AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA; Worldwide

The hazard

Affected lots are not performing to IFU criteria, showing cross reactions with 2-0 within 60 seconds. This cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.

Context

GovInfoNow's records show Remel Europe Ltd. has two other recalls on record since July 23, 2020. Other recent recalls of similar products include Oxoid Listeria Kits May Give Incorrect Results (March 3, 2026) and Remel Yeastone Broth Recall: Incorrect Lab Results Risk Delayed Treatment (March 24, 2026).

How to tell if you have this one

Check for lot numbers 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858 on the Oxoid Agglutinating Sera product.

Brand
Remel
Category
Medical device

Based on the official FDA remedy

What to do — step by step

Check Product Lot Number
Look for the lot numbers listed in the recall: 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 15 states.

FDA distribution: “Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, California, Florida, Illinois, Indiana, Iowa, Michigan, Minnesota, Missouri, Nebraska, North Carolina, Ohio, South Dakota, Texas, Washington.

Recall timeline

FDA published this recall 35 days after the firm started it.

Mar 25, 2026Firm started the recall
Apr 22, 2026FDA classified it Class II
Apr 29, 2026Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Is there a risk of serious injury from this product?

No, the recall is for lab testing accuracy, not physical safety risks. The hazard is limited to potential misidentification in food safety tests.

Similar recalls

Latest medical device recalls

Keep exploring

More Remel recalls

Link to this recall

<a href="https://govinfonow.com/recall/49625-remel-oxoid-agglutinating-sera-recall-cross-reaction-risk-with-salmonella">Remel Oxoid Agglutinating Sera Recall: Cross-reaction risk with Salmonella 9-0 (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #Z-1923-2026 (March 25, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1923-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.